Thu 28 March 2024
Warszawa (PL)
14/8°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
11 |
16 |
18 |
16 |
23 |
Thu 28 March 2024
Praha (CZ)
8/9°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
15 |
19 |
17 |
20 |
25 |
Thu 28 March 2024
Bratislava (SK)
11/10°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
15 |
16 |
16 |
19 |
23 |
Thu 28 March 2024
Budapest (HU)
13/10°C
Tue
|
Wed
|
Thu
|
Fri
|
Sat
|
15 |
18 |
15 |
21 |
24 |
July 14th, 2021
A second round of tests of people inoculated against coronavirus has shown that 88 percent have sufficient antibodies to protect them against the virus, Bela Merkely, the dean of Semmelweis University, told public broadcaster M1 on Wednesday, adding, however, that focusing on the level of antibodies as a marker for immunity was beside the point. "Clinical efficacy is the point in vaccination -- the extent to which the jab can protect patients from getting seriously ill," he said. "By that measure, all vaccines applied in Hungary have shown good results." Fully 1,195 people whose initial tests had indicated zero or a low level of antibodies were tested for a second time, Merkely said.
MTI
Pageviews this month:
39,099